1. Home
  2. NEON vs BLRX Comparison

NEON vs BLRX Comparison

Compare NEON & BLRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Neonode Inc.

NEON

Neonode Inc.

N/A

Current Price

$0.64

Market Cap

14.1M

Sector

Technology

ML Signal

N/A

Logo BioLineRx Ltd.

BLRX

BioLineRx Ltd.

N/A

Current Price

$1.95

Market Cap

11.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NEON
BLRX
Founded
1997
2003
Country
Sweden
Israel
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
14.1M
11.7M
IPO Year
1994
2010

Fundamental Metrics

Financial Performance
Metric
NEON
BLRX
Price
$0.64
$1.95
Analyst Decision
Analyst Count
0
0
Target Price
N/A
★ $22.00
AVG Volume (30 Days)
★ 50.3K
11.5K
Earning Date
11-11-2026
11-23-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 37.88
N/A
EPS
N/A
★ N/A
Revenue
★ $3,108,000.00
N/A
Revenue This Year
$69.35
$37.33
Revenue Next Year
$28.95
$37.06
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$0.63
$1.94
52 Week High
$2.89
$3.95

Technical Indicators

Market Signals
Indicator
NEON
BLRX
Relative Strength Index (RSI) 27.83 33.33
Support Level N/A $1.95
Resistance Level $0.95 $2.56
Average True Range (ATR) 0.06 0.14
MACD -0.01 0.00
Stochastic Oscillator 19.42 2.78

Price Performance

Historical Comparison
NEON
BLRX

About NEON Neonode Inc.

Neonode Inc provides software solutions for machine perception that feature machine learning algorithms to detect and track persons and objects in video streams from cameras and other types of imagers. Its machine perception solutions are based on the MultiSensing technology platform. The company also offers optical sensing solutions for contactless touch and gesture sensing. It markets and sells its solutions mainly to customers in the automotive sector, along with other markets such as office equipment, industrial automation, medical, military, and avionics. Geographically, the company operates in Japan, South Korea, Germany, Sweden, China, and other regions, with a majority of its revenue generated from Japan.

About BLRX BioLineRx Ltd.

BioLine Rx Ltd is a commercial-stage biopharmaceutical company focused on oncology. The company's current development and commercialization pipeline consists of two clinical-stage therapeutic candidates motixafortide (BL-8040), a novel peptide for the treatment of stem-cell mobilization and solid tumors, and AGI-134, an immuno-oncology agent in development for solid tumors. In addition, the company has a legacy therapeutic product called BL-5010 for the treatment of skin lesions. The company has generated revenues from milestone payments under previously existing out-licensing agreements.

Share on Social Networks: